Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United Kingdom (current)IrelandUnited StatesNew ZealandCanadaAustraliaScotlandNorthern Ireland

Company · Sheffield

Rinri Therapeutics Limited

Research and experimental development on biotechnology

How am I connected?
More
View network map Report an issue

Official record Companies House · updated 27th September 2026 · Sources

Network

The large node is Rinri Therapeutics Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 7

  1. Nicolas Andrew Higgins 2020-2023 Director View profile
  2. Dr Natalie Marianne Mount 2020-2023 Director View profile
  3. Dr Frank Axel Kalkbrenner 2019-2024 Director View profile
  4. Dr Detlev Mennerich 2019-2019 Director View profile
  5. Claire Brown 2019-2021 Director View profile
  6. Ross Alexander Mcmaster 2018-2022 Director View profile
  7. Anne Louise Taylor 2022-2022 Secretary View profile

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

About

What it does
Research and experimental development on biotechnology
Incorporated
15/11/2018
Registered office
Sheffield

Ownership

Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.

Group

  1. Rinri Therapeutics Limited is controlled by UK FF Nominees Limited
    Evidence
    active 25-50% shares, 25-50% voting · notified 2026-03-04 · source: Companies House PSC register
  2. UK FF Nominees Limited is controlled by UK FF Topco Limited
    Evidence
    active 75-100% shares, 75-100% voting, appoints directors · notified 2020-05-07 · source: Companies House PSC register
  3. UK FF Topco Limited is controlled by CSC Corporate Services (UK) Limited
    Evidence
    active 75-100% shares, 75-100% voting, appoints directors · notified 2020-05-07 · source: Companies House PSC register
  4. CSC Corporate Services (UK) Limited is controlled by CSC Capital Markets UK Limited
    Evidence
    active 75-100% shares, 75-100% voting, appoints directors · notified 2017-06-22 · source: Companies House PSC register
  5. CSC Capital Markets UK Limited is controlled by CSC Capital Markets Holding Company Limited
    Evidence
    active 75-100% shares, 75-100% voting, appoints directors · notified 2017-05-19 · source: Companies House PSC register
  6. CSC Capital Markets Holding Company Limited is controlled by CSC Financial Services Holdings Limited
    Evidence
    active 75-100% shares, 75-100% voting, appoints directors · notified 2017-05-19 · source: Companies House PSC register
  7. CSC Financial Services Holdings Limited is controlled by Corporation Service Company (Europe) Limited
    Evidence
    ceased 75-100% shares, 75-100% voting, appoints directors · notified 2017-05-10, ceased 2019-11-12 · source: Companies House PSC register

The PSC filings above Rinri Therapeutics Limited loop back on themselves; the chain is shown as far as it can be followed safely.

1,322 other companies in this group

Showing the first 50.

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Grants received

5 grants · £2,584,028 total

360Giving data, published by funders. Coverage only includes funders who publish their grants to 360Giving, so these figures are a floor, not a complete picture.

Top funders

  • Department for Business, Energy and Industrial Strategy · £2,436,186 (3 grants)
  • Department for Science, Innovation and Technology · £147,841 (2 grants)

Most recent

  • Department for Business, Energy and Industrial Strategy £9,0662022-04-01
  • Department for Business, Energy and Industrial Strategy £809,0402021-04-01
  • Department for Business, Energy and Industrial Strategy £1,618,0802021-03-01
  • Department for Science, Innovation and Technology £132,0282021-01-11
  • Department for Science, Innovation and Technology £15,8132020-09-11
Board analysis

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

5 directors on the board

4.7y median 4.9y
average tenure
7.7y
longest tenure

Directors past 6 years

First-time vs portfolio directors

First-time (3)

Portfolio (2)

0
also govern a charity
0
left in the last 12 months

Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.

Professional services 2Arts and leisure 1Property 1

The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.

Gaps to watch

  • Narrow spread of sectors across the board

Where to look Suggested search: directors from a wider range of sectors.

Sources

Official record from Companies House. Governance Register calculates the connections.

Record details
Company number
11680455
Status
Active
Type
Private Limited Company
Accounts next due
30/09/2027
Edition
Register edition compiled 27th September 2026
Labels
Official record from Companies House · Calculated derived by Governance Register.

Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data